Table 2.
Laboratory Characteristics of the Three Studied Groups
| HCC group n=38 | Cirrhosis group n=38 | Control group n=38 | p-value | ||
|---|---|---|---|---|---|
| p3=0.095 | |||||
| Hemoglobin (gm/dL) | 11.4±1.3 | 11.7±2.1 | 13.2±0.9 | <0.001 | p1=0.659 |
| p2<0.001 | |||||
| p3=0.010 | |||||
| TLC x103 | 6.6±3.8 | 6.7±2.9 | 7.1±2.2 | 0.693 | |
| Platelet count x103 | 151±61 | 174±82 | 250±54 | <0.001 | p1=0.467 |
| p2<0.001 | |||||
| p3=0.001 | |||||
| Albumin (gm/dL) | 3.23±0.49 | 3.51±0.53 | 4.54±0.62 | <0.001 | p1=0.325 |
| p2<0.001 | |||||
| p3=0.012 | |||||
| T. Bilirubin (mg/dL) | 1.5 (0.8-4.3) | 1.1 (0.1-3.3) | 0.7 (0.1-1.8) | 0.002 | p1=0.039 |
| p2=0.004 | |||||
| p3=0.633 | |||||
| D. Bilirubin (mg/dL) | 0.7 (0.1-2.2) | 0.4 (0.1-1.6) | 0.3 (0.2-0.7) | 0.057 | |
| ALT (IU/mL) | 48 (12-198) | 28 (12-139) | 20 (12-28) | 0.005 | p1=0.241 |
| p2=0.005 | |||||
| p3=0.183 | |||||
| AST (IU/mL) | 55 (18-271) | 35 (1-78) | 17 (10-30) | <0.001 | p1<0.001 |
| p2<0.001 | |||||
| p3=0.078 | |||||
| INR | 1.53±0.37 | 1.33±0.21 | 1.02±0.09 | <0.001 | p1=0.161 |
| p2<0.001 | |||||
| p3=0.001 | |||||
| S. creatinine (mg/dL) | 1.16±0.39 | 0.99±0.33 | 0.83±0.27 | 0.003 | p1=0.341 |
| p2=0.002 | |||||
| p3=0.300 | |||||
| B. urea (mg/dL) | 32.5 (15-98) | 24 (12-45) | 18 (6-23) | 0.001 | p1=0.148 |
| p2=0.001 |
Data are presented as mean±SD or median (range); TLC,Total leucocytic count; ALT, Alanine transaminase; AST, Aspartate aminotransferase; INR, International normalized ratio; p1, HCC vs. Cirrhosis; p2, HCC vs. Control; p3, Cirrhosis vs. Control